Skip to main content

Research Repository

Advanced Search

Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?

Clarke, Carl E.; Patel, Smitaa; Ives, Natalie; Rick, Caroline; Wheatley, Keith; Gray, Richard

Authors

Carl E. Clarke

Smitaa Patel

Natalie Ives

Keith Wheatley

Richard Gray



Abstract

Background:

Evidence from clinical trials with monoamine oxidase type B inhibitors (TEMPO, ADAGIO and DATATOP) and levodopa (ELLDOPA) suggests that Parkinson's disease patients may benefit from treatment being commenced immediately on diagnosis rather than waiting for functional disability to develop, as is traditional clinical practice.

Methods:

We performed a narrative literature review and meta‐analysis of delayed‐start design trials in Parkinson's disease.

Results:

There was inconsistency in the results of the two rasagiline delayed‐start design trials, with early treatment with a 2 mg dose significantly superior in the TEMPO trial, but the 1 mg dose significantly better in the ADAGIO trial, making interpretation difficult. Further, the benefits of immediate treatment were small in terms of total unified Parkinson's disease rating scale scores, with a mean difference of 0.91 units (95% confidence interval 0.01, 1.80; P=0.05) in a meta‐analysis of the TEMPO and ADAGIO delayed‐start design trials. Such small differences are unlikely to be of clinical relevance. There is also little information on whether immediate treatment has a beneficial effect on patient quality of life with an acceptable adverse reaction profile, and we have no data on whether imediate treatment is cost‐effective.

Discussion:

Based on the evidence available, changing clinical practice to immediate therapy on diagnosis is not warranted and further trials are needed. © 2011 Movement Disorder Society

Citation

Clarke, C. E., Patel, S., Ives, N., Rick, C., Wheatley, K., & Gray, R. (2011). Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?. Movement Disorders, 26(7), 1187-1193. https://doi.org/10.1002/mds.23519

Journal Article Type Article
Acceptance Date Oct 13, 2010
Online Publication Date Apr 14, 2011
Publication Date 2011-06
Deposit Date Jun 27, 2019
Journal Movement Disorders
Print ISSN 0885-3185
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 26
Issue 7
Pages 1187-1193
DOI https://doi.org/10.1002/mds.23519
Keywords Neurology; Clinical Neurology
Public URL https://nottingham-repository.worktribe.com/output/2235494
Publisher URL https://onlinelibrary.wiley.com/doi/abs/10.1002/mds.23519